• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型吡唑啉衍生物作为潜在抗肝癌药物在HepG-2细胞系中的合成与评价

Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticancer Agents in HepG-2 Cell Line.

作者信息

Xu Weijie, Pan Ying, Wang Hong, Li Haiyan, Peng Qing, Wei Duncan, Chen Cheng, Zheng Jinhong

机构信息

Department of Chemistry, Shantou University Medical College, Shantou 515041, Guangdong, China.

Department of Pharmacology, Shantou University Medical College, Shantou 515041, Guangdong, China.

出版信息

Molecules. 2017 Mar 16;22(3):467. doi: 10.3390/molecules22030467.

DOI:10.3390/molecules22030467
PMID:28300751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6155299/
Abstract

Cancer is a major public health concern worldwide. Adverse effects of cancer treatments still compromise patients' quality of life. To identify new potential anticancer agents, a series of novel pyrazoline derivatives were synthesized and evaluated for cytotoxic effects on HepG-2 (human liver hepatocellular carcinoma cell line) and primary hepatocytes. Compound structures were confirmed by ¹H-NMR, mass spectrometry, and infrared imaging. An in vitro assay demonstrated that several compounds exerted cytotoxicity in the micromolar range. Benzo[]thiophen-2-yl-[5-(4-hydroxy-3,5-dimethoxy-phenyl)-3-(2-hydroxy-phenyl)-4,5-dihydo-pyrazol-1-yl]-methanone () was the most effective anticancer agent against HepG-2 cells owing to its notable inhibitory effect on HepG-2 with an IC value of 3.57 µM when compared with cisplatin (IC = 8.45 µM) and low cytotoxicity against primary hepatocytes. Cell cycle analysis and apoptosis/necrosis evaluation using this compound revealed that notably arrested HepG-2 cells in the G₂/M phase and induced HepG-2 cells apoptosis. Our findings indicate that compound may be a promising anticancer drug candidate.

摘要

癌症是全球主要的公共卫生问题。癌症治疗的副作用仍然会影响患者的生活质量。为了确定新的潜在抗癌药物,合成了一系列新型吡唑啉衍生物,并评估了它们对HepG-2(人肝癌细胞系)和原代肝细胞的细胞毒性作用。通过¹H-NMR、质谱和红外成像确认了化合物结构。体外试验表明,几种化合物在微摩尔范围内具有细胞毒性。苯并[]噻吩-2-基-[5-(4-羟基-3,5-二甲氧基苯基)-3-(2-羟基苯基)-4,5-二氢吡唑-1-基]-甲酮()是针对HepG-2细胞最有效的抗癌药物,因为它对HepG-2具有显著的抑制作用,IC值为3.57 µM,与顺铂(IC = 8.45 µM)相比,对原代肝细胞的细胞毒性较低。使用该化合物进行的细胞周期分析和凋亡/坏死评估显示,显著使HepG-2细胞停滞在G₂/M期并诱导HepG-2细胞凋亡。我们的研究结果表明,化合物可能是一种有前景的抗癌药物候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a25/6155299/bfe9d185d2ed/molecules-22-00467-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a25/6155299/2b2e17c34a82/molecules-22-00467-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a25/6155299/8279d72ba1d2/molecules-22-00467-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a25/6155299/86db32d65d91/molecules-22-00467-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a25/6155299/059eea79f308/molecules-22-00467-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a25/6155299/bfe9d185d2ed/molecules-22-00467-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a25/6155299/2b2e17c34a82/molecules-22-00467-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a25/6155299/8279d72ba1d2/molecules-22-00467-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a25/6155299/86db32d65d91/molecules-22-00467-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a25/6155299/059eea79f308/molecules-22-00467-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a25/6155299/bfe9d185d2ed/molecules-22-00467-g004.jpg

相似文献

1
Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticancer Agents in HepG-2 Cell Line.新型吡唑啉衍生物作为潜在抗肝癌药物在HepG-2细胞系中的合成与评价
Molecules. 2017 Mar 16;22(3):467. doi: 10.3390/molecules22030467.
2
A New Series of Cytotoxic Pyrazoline Derivatives as Potential Anticancer Agents that Induce Cell Cycle Arrest and Apoptosis.一系列新型细胞毒性吡唑啉衍生物作为潜在的抗癌药物,诱导细胞周期停滞和细胞凋亡。
Molecules. 2017 Sep 29;22(10):1635. doi: 10.3390/molecules22101635.
3
Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticancer Agents.新型吡唑啉衍生物作为潜在抗癌剂的合成与评价
Molecules. 2015 Oct 20;20(10):19066-84. doi: 10.3390/molecules201019066.
4
Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors.新型含吡唑啉衍生物作为潜在微管蛋白组装抑制剂的设计、合成及生物学评价
Eur J Med Chem. 2015 Apr 13;94:447-57. doi: 10.1016/j.ejmech.2015.02.058. Epub 2015 Mar 3.
5
Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.新型3,6-二甲基-1-苯基-4-(取代甲氧基)吡唑并[3,4-d]嘧啶衍生物的合成、表皮生长因子受体抑制作用及抗癌活性
Anticancer Agents Med Chem. 2017;17(10):1389-1400. doi: 10.2174/1872211311666170213105004.
6
Pyrazoline analogs as potential anticancer agents and their apoptosis, molecular docking, MD simulation, DNA binding and antioxidant studies.吡唑啉类似物作为潜在的抗癌剂及其细胞凋亡、分子对接、MD 模拟、DNA 结合和抗氧化研究。
Bioorg Chem. 2021 Mar;108:104665. doi: 10.1016/j.bioorg.2021.104665. Epub 2021 Jan 27.
7
A novel series of thiazolyl-pyrazoline derivatives: synthesis and evaluation of antifungal activity, cytotoxicity and genotoxicity.新型噻唑基-吡唑啉衍生物系列:抗真菌活性、细胞毒性和遗传毒性评价。
Eur J Med Chem. 2015 Mar 6;92:342-52. doi: 10.1016/j.ejmech.2014.12.055. Epub 2014 Dec 31.
8
Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.硫代卡巴腙铜(II)和锌(II)配合物作为潜在的抗癌剂:合成、晶体结构、DNA裂解、细胞毒性和凋亡诱导活性。
J Inorg Biochem. 2014 Jul;136:13-23. doi: 10.1016/j.jinorgbio.2014.03.004. Epub 2014 Mar 16.
9
Synthesis and cytotoxic activity of some novel steroidal C-17 pyrazolinyl derivatives.一些新型甾体 C-17 吡唑啉基衍生物的合成及细胞毒性活性。
Eur J Med Chem. 2013 Nov;69:182-90. doi: 10.1016/j.ejmech.2013.08.016. Epub 2013 Aug 19.
10
Synthesis of 1-acetyl-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives and evaluation of their anticancer activity.合成 1-乙酰基-3-(2-噻吩基)-5-芳基-2-吡唑啉衍生物及其抗癌活性评价。
J Enzyme Inhib Med Chem. 2013 Dec;28(6):1221-7. doi: 10.3109/14756366.2012.724682. Epub 2012 Oct 1.

引用本文的文献

1
3,5-Disubstituted pyrazoline as a promising core for anticancer agents: mechanisms of action and therapeutic potentials.3,5-二取代吡唑啉作为一种有前景的抗癌药物核心结构:作用机制与治疗潜力
Future Med Chem. 2025 Mar;17(6):725-745. doi: 10.1080/17568919.2025.2476393. Epub 2025 Mar 13.
2
Synthetic Approaches, Biological Activities, and Structure-Activity Relationship of Pyrazolines and Related Derivatives.吡唑啉及相关衍生物的合成方法、生物活性及构效关系。
Top Curr Chem (Cham). 2023 Apr 8;381(3):12. doi: 10.1007/s41061-023-00422-z.
3
Effects of Bacillus subtilis iturin A on HepG2 cells in vitro and vivo.

本文引用的文献

1
The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line.极光激酶抑制剂VX-680在原发性转移细胞和SW13细胞系中显示出抗癌作用。
Invest New Drugs. 2016 Oct;34(5):531-40. doi: 10.1007/s10637-016-0358-3. Epub 2016 May 14.
2
The p38 MAPK inhibitor BIRB796 enhances the antitumor effects of VX680 in cervical cancer.p38丝裂原活化蛋白激酶抑制剂BIRB796增强了VX680对宫颈癌的抗肿瘤作用。
Cancer Biol Ther. 2016 May 3;17(5):566-76. doi: 10.1080/15384047.2016.1177676.
3
Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline-thiazolidine-based hybrids.
枯草芽孢杆菌伊枯草菌素A对HepG2细胞的体内外作用
AMB Express. 2021 May 10;11(1):67. doi: 10.1186/s13568-021-01226-4.
4
Pyrazoline Hybrids as Promising Anticancer Agents: An Up-to-Date Overview.吡唑啉杂合体作为有前途的抗癌剂:最新概述。
Int J Mol Sci. 2020 Jul 31;21(15):5507. doi: 10.3390/ijms21155507.
5
Design, synthesis, molecular modelling, and biological evaluation of novel substituted pyrimidine derivatives as potential anticancer agents for hepatocellular carcinoma.新型取代嘧啶衍生物的设计、合成、分子模拟及作为潜在肝癌治疗药物的生物评价。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):1110-1120. doi: 10.1080/14756366.2019.1612889.
6
Synthesis and Biological Evaluation of Novel Alkyl Amine Substituted Icariside II Derivatives as Potential Anticancer Agents.新型烷基胺取代淫羊藿次苷 II 衍生物的合成及生物评价作为潜在的抗癌剂。
Molecules. 2018 Aug 27;23(9):2146. doi: 10.3390/molecules23092146.
7
Potential of Bacillus subtilis lipopeptides in anti-cancer I: induction of apoptosis and paraptosis and inhibition of autophagy in K562 cells.枯草芽孢杆菌脂肽在抗癌方面的潜力I:诱导K562细胞凋亡和类凋亡以及抑制自噬
AMB Express. 2018 May 9;8(1):78. doi: 10.1186/s13568-018-0606-3.
基于具有药理活性的吡唑/吡唑啉-噻唑烷杂化物的合成方法、构效关系及生物学应用
Eur J Med Chem. 2016 May 4;113:145-66. doi: 10.1016/j.ejmech.2016.02.030. Epub 2016 Feb 16.
4
Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticancer Agents.新型吡唑啉衍生物作为潜在抗癌剂的合成与评价
Molecules. 2015 Oct 20;20(10):19066-84. doi: 10.3390/molecules201019066.
5
Novel 1,4-naphthoquinone-based sulfonamides: Synthesis, QSAR, anticancer and antimalarial studies.新型 1,4-萘醌基磺酰胺类化合物的合成、QSAR、抗癌和抗疟研究。
Eur J Med Chem. 2015 Oct 20;103:446-59. doi: 10.1016/j.ejmech.2015.09.001. Epub 2015 Sep 5.
6
The HIF-1 inhibitor YC-1 decreases reactive astrocyte formation in a rodent ischemia model.缺氧诱导因子-1抑制剂YC-1可减少啮齿动物缺血模型中反应性星形胶质细胞的形成。
Am J Transl Res. 2015 Apr 15;7(4):751-60. eCollection 2015.
7
Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors.新型含吡唑啉衍生物作为潜在微管蛋白组装抑制剂的设计、合成及生物学评价
Eur J Med Chem. 2015 Apr 13;94:447-57. doi: 10.1016/j.ejmech.2015.02.058. Epub 2015 Mar 3.
8
Synthesis and in vitro antitumor activity of a novel series of 2-pyrazoline derivatives bearing the 4-aryloxy-7-chloroquinoline fragment.一系列带有4-芳氧基-7-氯喹啉片段的新型2-吡唑啉衍生物的合成及其体外抗肿瘤活性
Molecules. 2014 Nov 14;19(11):18656-75. doi: 10.3390/molecules191118656.
9
Hepatocellular carcinoma in the world and the middle East.全球及中东地区的肝细胞癌
Middle East J Dig Dis. 2010 Jan;2(1):31-41.
10
YC-1 inhibits proliferation of breast cancer cells by down-regulating EZH2 expression via activation of c-Cbl and ERK.YC-1通过激活c-Cbl和ERK下调EZH2表达来抑制乳腺癌细胞增殖。
Br J Pharmacol. 2014 Sep;171(17):4010-25. doi: 10.1111/bph.12708. Epub 2014 Jul 25.